Changes of the laboratory indicators of hemostasis in hepatopathy
																	
									Authors:
											R. Hrabcová						1,4; 											P. Kessler						2; 											J. Gumulec						1; 											M. Kouri						3										
				
									Authors‘ workplace:
											Ústav klinické hematologie FN Ostrava, přednosta prim. MUDr. Jaromír Gumulec
						1; 											Oddělení hematologie a transfuziologie Nemocnice Pelhřimov, p. o., přednosta prim. MUDr. Petr Kessler
						2; 											BioMerieux, South Africa, general manager Marcin Kouri
						3; 											SPADIA LAB a. s., Česká republika, ředitel RNDr. Martin Radina
						4										
				
									Published in:
					Vnitř Lék 2010; 56(Supplementum 1): 120-122
					
				
									Category:
					16th Parizek's Days, Ostrava-Poruba, March 25th –26th 2010
					
				
							
Overview
The liver has a central role in hemostasis. It is the major site of synthesis of the coagulation factors, inhibitors and components of fibrinolytic system. The liver also functions as a site for clearance of their activated forms from the circulation. Liver disease leads to a shift in the delicately controlled hemostatic system in both primary and secondary hemostasis.
Key words:
 liver disease – thrombocytopenia – platelet dysfunction – coagulation abnormalities – DIC
Sources
1. Irwin R, Rippe J. Irwin and Rippe’s Intensive Care Medicine. 6th ed. Lippincott Williams & Wilkins 2008.
2. Irwin RS, Rippe JM. Manual of Intensive Care Medicine. 4th ed. Lippincott Williams & Wilkins 2006.
3. Fiebach NH, Kern DE, Thomas PA et al. Principles of Ambulatory Medicine. 7th ed. Lippincott Williams & Wilkins 2007.
4. Avunduk C. Manual of Gastroenterology: Diagnosis and Therapy. 3rd ed. Lippincott Williams & Wilkins 2002.
5. Schiff ER, Sorrell MF, Maddrey WC. Schiff‘s Diseases of the Liver. 10th ed. Lippincott Williams & Wilkins 2007.
6. Wright M, Goldin R, Hellier S et al. Factor V Leiden polymorphism and the rate of fibrosis development on chronic hepatitis C virus infection. Gut 2003; 52 : 1206–1210.
7. Colman RW, Clowes AW, Goldhaber SZ et al. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. Lippincott Williams & Wilkins 2006.
8. McClatchey KD. Clinical Laboratory Medicine. 2nd ed. Lippincott Williams & Wilkins 2002.
9. Kyung SS, Hyun KK, Jae WS. Measurement of thrombus precursor protein in septic patient with disseminated intravascular coagulation and liver disease. Haematologica 2002; 87 : 1062–1067.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
 
					2010 Issue Supplementum 1
Most read in this issue
- Thrombocytopenia and coagulopathy in hepatopathy: an introduction into the issue
- Monitoring of coagulation parameters and options to influence them in patients with liver cirrhosis prior to invasive procedures
- Differential diagnosis of thrombocytopaenia in pregnancy
- The application of IPF (Immature platelet fraction) in laboratory diagnostics